Cargando…

P891: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RRMM PATIENTS: RESULTS OF THE MULTICENTER PHASE 2 STUDY (IFM 2018-02) OF THE INTERGROUPE FRANCOPHONE DU MYÉLOME (IFM).

Detalles Bibliográficos
Autores principales:	Macro, Margaret, Touzeau, Cyrille, Mariette, Clara, Manier, Salomon, Brechignac, Sabine, Vincent, Laure, Hebraud, Benjamin, Decaux, Olivier, Schulmann, Samantha, Lenoir, Caroline, Godmer, Pascal, Farge, Agathe, Paul, Laure Peyro Saint, Parienti, Jean-Jacques, Leleu, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430929/ http://dx.doi.org/10.1097/01.HS9.0000970468.19468.a4

Ejemplares similares

P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM).
por: Macro, M., et al.
Publicado: (2022)

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01
por: Bobin, A., et al.
Publicado: (2022)

Draft Genome Sequence of Aspergillus awamori IFM 58123(NT)
por: Shimizu, Masaaki, et al.
Publicado: (2019)

The JNU-IFM dataset for segmenting pubic symphysis-fetal head
por: Lu, Yaosheng, et al.
Publicado: (2022)

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study
por: Dumontet, Charles, et al.
Publicado: (2023)

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
por: Touzeau, Cyrille, et al.
Publicado: (2022)

Improved De Novo Draft Genome Sequence of the Nocavionin-Producing Type Strain Nocardia terpenica IFM 0706 and Comparative Genomics with the Closely Related Strain Nocardia terpenica IFM 0406
por: Buchmann, Anina, et al.
Publicado: (2020)

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
por: Talbot, Alexis, et al.
Publicado: (2023)

Draft Genome Sequence of the Pathogenic Filamentous Fungus Aspergillus lentulus IFM 54703(T)
por: Kusuya, Yoko, et al.
Publicado: (2016)

Difficulties in immunofixation analysis: a concordance study on the IFM 2007-02 trial
por: Caillon, H, et al.
Publicado: (2013)

Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)
por: van de Wyngaert, Zoe, et al.
Publicado: (2023)

Draft Genome Sequence of the Pathogenic Filamentous Fungus Aspergillus udagawae Strain IFM 46973(T)
por: Kusuya, Yoko, et al.
Publicado: (2015)

Block of Brain Sodium Channels by Peptide Mimetics of the Isoleucine, Phenylalanine, and Methionine (IFM) Motif from the Inactivation Gate
por: Eaholtz, Galen, et al.
Publicado: (1999)

The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2021)

Corrigendum to “The JNU-IFM dataset for segmenting pubic symphysis-fetal head” data in brief. 41 (2022) 107904
por: Lu, Yaosheng, et al.
Publicado: (2022)

Immunofluorescence microscopy (IFM) analysis of primary ciliary dyskinesia (PCD) patients with suspected inner dynein arm defects (IDA)
por: Hjeij, R, et al.
Publicado: (2012)

New Nocobactin Derivatives with Antimuscarinic Activity, Terpenibactins A–C, Revealed by Genome Mining of Nocardia terpenica IFM 0406
por: Chen, Julia, et al.
Publicado: (2020)

Integrated formal methods: 14th international conference, IFM 2018, Maynooth, Ireland, September 5-7, 2018, proceedings
por: Furia, Carlo A, et al.
Publicado: (2018)

Integrated formal methods: 13th international conference, IFM 2017, Turin, Italy, September 20-22, 2017, proceedings
por: Polikarpova, Nadia, et al.
Publicado: (2017)

Integrated formal methods: 15th international conference, IFM 2019, Bergen, Norway, December 2-6, 2019, proceedings
por: Ahrendt, Wolfgang, et al.
Publicado: (2019)

Integrated formal methods: 12th international conference, IFM 2016, Reykjavik, Iceland, June 1-5, 2016, proceedings
por: Ábrahám, Erika, et al.
Publicado: (2016)

Immunoprotective Analysis of the NFA49590 Protein from Nocardia farcinica IFM 10152 Demonstrates Its Potential as a Vaccine Candidate
por: Han, Lichao, et al.
Publicado: (2022)

News and Views (5&6): 50th Anniversary of IFM; A Panel Discussion at IUPAP100; Relaunch of Asian Network
Publicado: (2023)

S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
por: Bahlis, Nizar J, et al.
Publicado: (2023)

Kinetic Analysis of Block of Open Sodium Channels by a Peptide Containing the Isoleucine, Phenylalanine, and Methionine (IFM) Motif from the Inactivation Gate
por: Eaholtz, Galen, et al.
Publicado: (1998)

Ifm(2)2 is a myosin heavy chain allele that disrupts myofibrillar assembly only in the indirect flight muscle of Drosophila melanogaster
Publicado: (1988)

High-Quality Draft Genome Sequence of the Actinobacterium Nocardia terpenica IFM 0406, Producer of the Immunosuppressant Brasilicardins, Using Illumina and PacBio Technologies
por: Buchmann, Anina, et al.
Publicado: (2016)

Dara Ó Briain's visit to CERN
por: Rao, Achintya
Publicado: (2017)

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG (IMID) AND A PROTEASOME INHIBITOR (PI) OR HAD RECEIVED ≥3 PRIOR LINES OF THERAPY INCLUDING AN IMID AND A PI
por: Mateos, M, et al.
Publicado: (2023)

Multiples Myelom und COVID-19
por: Ayazpoor, Ute
Publicado: (2021)

Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM
por: Jeryczynski, Georg, et al.
Publicado: (2021)

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY
por: Offner, Fritz, et al.
Publicado: (2023)

Pide y se te dará : aprende a manifestar tus deseos /
por: Hicks, Esther
Publicado: (2005)

Multiples Myelom in der COVID-19-Pandemie
por: von Kieseritzky, Kathrin
Publicado: (2021)

Prise en charge du myélome multiple
por: Lee, Ann S., et al.
Publicado: (2021)

CAR-T-Zell-Therapie beim multiplen Myelom
por: Zhou, X., et al.
Publicado: (2021)

Bilaterale orbitale Affektion bei multiplem Myelom
por: Khalil, Baran, et al.
Publicado: (2023)

Highlight: Francophone
Publicado: (2007)

Are There Mental Health Differences Between Francophone and Non-Francophone Populations in Manitoba?
por: Chartier, Mariette Jeanne, et al.
Publicado: (2014)

Cristina dará hoy su discurso en la OIT
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qil18f3vert4bm0h8ihi52rdqr